Annexin-A1: Therapeutic potential in microvascular disease
Annexin-A1 (ANXA1) was first discovered in the early 1980's as a protein, which mediates (some of the) anti-inflammatory effects of glucocorticoids. Subsequently, the role of ANXA1 in inflammation has been extensively studied. The biology of ANXA1 is complex and it has many different roles in b...
Váldodahkkit: | Purvis, G, Solito, E, Thiemermann, C |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Frontiers Media
2019
|
Geahča maid
-
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
Dahkki: Purvis, G, et al.
Almmustuhtton: (2017) -
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
Dahkki: Zhibin Yan, et al.
Almmustuhtton: (2022-11-01) -
Annexin 1 and the regulation of endocrine function.
Dahkki: John, C, et al.
Almmustuhtton: (2004) -
Annexin A1 in the brain--undiscovered roles?
Dahkki: Solito, E, et al.
Almmustuhtton: (2008) -
Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.
Dahkki: Buckingham, J, et al.
Almmustuhtton: (2006)